Motor activity of vascularly perfused rat duodenum. 2. Effects of VIP, PACAP27 and PACAP38.
We examined the mechanisms of effects of vasoactive intestinal polypeptide (VIP), pituitary adenylate cyclase activating polypeptide (PACAP) 27 and PACAP38 on spontaneously occurring pressure waves in ex vivo perfused rat duodenum. VIP and PACAPs dose-dependently reduced the percentage motor index of pressure waves; this reduction was not prevented by atropine, hexamethonium or tetrodotoxin (TTX). VIP and PACAPs abolished acetylcholine-induced stimulation of pressure waves, even in the presence of TTX. These findings suggest that VIP and PACAPs may exert direct inhibitory effects via VIP/PACAP receptors located on smooth muscle rather than via cholinergic receptors. The inhibitory effects of VIP and PACAPs were partially antagonized by the VIP receptor antagonists VIP(10-28), suggesting that VIP and PACAPs share common receptor sites on intestinal smooth muscle. The effects of VIP and PACAPs were completely antagonized by nitric oxide (NO) synthase inhibitor NG-nitro-L-arginine (L-NA), suggesting that NO mediates the inhibitory effects of VIP and PACAPs on duodenal motility. Furthermore, single injection of L-NA stimulated spontaneously occurring pressure waves, while VIP(10-28) did not affect them. These findings suggest that VIP/PACAPs and NO strongly interact as an inhibitory mediator on duodenal motility, but that their modes of action in doing so may differ.
Yamamoto
H
H
Department of Anatomy, Shiga University of Medical Science, Otsu, Shiga, 520-2192 Japan. yhiroshi@belle.shiga-med.ac.jp
Kuwahara
A
A
Fujimura
M
M
Maeda
T
T
Fujimiya
M
M
D000818:Animals; D004386:Duodenum / Q000098:blood supply*; D005769:Gastrointestinal Motility / Q000187:drug effects*; D009479:Neuropeptides / Q000494:pharmacology*; D019335:Nitroarginine / Q000494:pharmacology; D010477:Perfusion; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D051381:Rats; D013779:Tetrodotoxin / Q000494:pharmacology; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology*
C495403:Adcyap1 protein, rat; D009479:Neuropeptides; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D014665:Vasodilator Agents; D019335:Nitroarginine; D014660:Vasoactive Intestinal Peptide; D013779:Tetrodotoxin